Purpose of Review To report the standard of care, latest advances, interesting new findings, and controversies about the treatment of Bell’s palsy in the acute phase. Recent Findings Treatment with prednisolone alone within 72 h still is the treatment standard. The role of antivirals still is unclear. Since 2009, no trials with influence on the treatment standards have been performed. A study to clarify the role of prednisolone treatment in children is ongoing. Patient-related outcome measures like the Facial Clinimetric Evaluation Scale and the Facial Disability Index are important tools to assess the quality of life and psychosocial impact of Bell’s palsy next to the motor deficits. Simplified subjective electronic grading systems like the eFACE and first automated image analysis systems have been introduced. Summary Studies clarifying the role of antivirals for severe cases are urgently needed as well as an international consensus on the outcome measures in diagnostics and follow-up. . . . . . Keywords Facial palsy Diagnostics Prednisolone Corticosteroids Guidelines Adjuvant therapy Introduction hallmark studies from Scotland and Scandinavia, there is high evidence for the effectiveness of an exclusive corticosteroid Bell’s palsy still is a disease of unknown etiology and a diag- treatment if started within
Current Otorhinolaryngology Reports – Springer Journals
Published: Apr 21, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera